{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:24:59Z","timestamp":1772119499211,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tech Coloproctol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10151-024-03050-x","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T05:42:51Z","timestamp":1734586971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Urge fecal incontinence: are intramural rectal injections of botulinum toxin a long-term treatment option?"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4859-5619","authenticated-orcid":false,"given":"Philippe","family":"Onana Ndong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Baumstarck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Vitton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"3050_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/s0399-8320(06)73076-7","volume":"30","author":"H Damon","year":"2006","unstructured":"Damon H, Guye O, Seigneurin A et al (2006) Prevalence of anal incontinence in adults and impact on quality-of-life. Gastroenterol Clin Biol 30:37\u201343. https:\/\/doi.org\/10.1016\/s0399-8320(06)73076-7","journal-title":"Gastroenterol Clin Biol"},{"issue":"512\u2013517","key":"3050_CR2","doi-asserted-by":"publisher","first-page":"517.e1","DOI":"10.1053\/j.gastro.2009.04.054","volume":"137","author":"WE Whitehead","year":"2009","unstructured":"Whitehead WE, Borrud L, Goode PS et al (2009) Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology 137(512\u2013517):517.e1\u20132. https:\/\/doi.org\/10.1053\/j.gastro.2009.04.054","journal-title":"Gastroenterology"},{"key":"3050_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/pl00004031","volume":"12","author":"DL Faltin","year":"2001","unstructured":"Faltin DL, Sangalli MR, Curtin F et al (2001) Prevalence of anal incontinence and other anorectal symptoms in women. Int Urogynecol J Pelvic Floor Dysfunct 12:117\u2013120. https:\/\/doi.org\/10.1007\/pl00004031","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"3050_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4291\/wjgp.v7.i1.59","volume":"7","author":"MB Alban Benezech","year":"2016","unstructured":"Alban Benezech MB, Vitton R (2016) Faecal incontinence: current knowledges and perspectives. World J Gastrointest Pathophysiol 7:59\u201371. https:\/\/doi.org\/10.4291\/wjgp.v7.i1.59","journal-title":"World J Gastrointest Pathophysiol"},{"key":"3050_CR5","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/s0140-6736(94)92213-6","volume":"344","author":"MA Kamm","year":"1994","unstructured":"Kamm MA (1994) Obstetric damage and faecal incontinence. Lancet 344:730\u2013733. https:\/\/doi.org\/10.1016\/s0140-6736(94)92213-6","journal-title":"Lancet"},{"key":"3050_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/bjs.9740","volume":"102","author":"DF Altomare","year":"2015","unstructured":"Altomare DF, Giuratrabocchetta S, Knowles CH et al (2015) Long-term outcomes of sacral nerve stimulation for faecal incontinence. Br J Surg 102:407\u2013415. https:\/\/doi.org\/10.1002\/bjs.9740","journal-title":"Br J Surg"},{"key":"3050_CR7","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/j.jviscsurg.2021.12.004","volume":"159","author":"C Desprez","year":"2022","unstructured":"Desprez C, Bridoux V, Leroi A-M (2022) Disorders of anorectal motility: functional defecation disorders and fecal incontinence. J Visc Surg 159:S40\u2013S50. https:\/\/doi.org\/10.1016\/j.jviscsurg.2021.12.004","journal-title":"J Visc Surg"},{"key":"3050_CR8","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.surg.2016.10.038","volume":"161","author":"PTJ Janssen","year":"2017","unstructured":"Janssen PTJ, Kuiper SZ, Stassen LPS et al (2017) Fecal incontinence treated by sacral neuromodulation: long-term follow-up of 325 patients. Surgery 161:1040\u20131048. https:\/\/doi.org\/10.1016\/j.surg.2016.10.038","journal-title":"Surgery"},{"key":"3050_CR9","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/DCR.0000000000000594","volume":"59","author":"ML Forte","year":"2016","unstructured":"Forte ML, Andrade KE, Lowry AC et al (2016) Systematic review of surgical treatments for fecal incontinence. Dis Colon Rectum 59:443\u2013469. https:\/\/doi.org\/10.1097\/DCR.0000000000000594","journal-title":"Dis Colon Rectum"},{"key":"3050_CR10","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1463-1318.2011.02585.x","volume":"14","author":"V Bridoux","year":"2012","unstructured":"Bridoux V, Gourcerol G, Kianifard B et al (2012) Botulinum A toxin as a treatment for overactive rectum with associated faecal incontinence. Colorectal Dis 14:342\u2013348. https:\/\/doi.org\/10.1111\/j.1463-1318.2011.02585.x","journal-title":"Colorectal Dis"},{"key":"3050_CR11","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1055\/s-0034-1393242","volume":"48","author":"G Gourcerol","year":"2016","unstructured":"Gourcerol G, B\u00e9nard C, Melchior C et al (2016) Botulinum toxin: an endoscopic approach for treating fecal incontinence. Endoscopy 48:484\u2013488. https:\/\/doi.org\/10.1055\/s-0034-1393242","journal-title":"Endoscopy"},{"key":"3050_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00332-1","author":"A-M Leroi","year":"2023","unstructured":"Leroi A-M, Queralto M, Zerbib F et al (2023) Intrarectal injections of botulinum toxin versus placebo for the treatment of urge faecal incontinence in adults (FI-Toxin): a double-blind, multicentre, randomised, controlled phase 3 study. Lancet Gastroenterol Hepatol. https:\/\/doi.org\/10.1016\/S2468-1253(23)00332-1","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3050_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BF02050307","volume":"36","author":"JM Jorge","year":"1993","unstructured":"Jorge JM, Wexner SD (1993) Etiology and management of fecal incontinence. Dis Colon Rectum 36:77\u201397. https:\/\/doi.org\/10.1007\/BF02050307","journal-title":"Dis Colon Rectum"},{"key":"3050_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","volume":"53","author":"G Karsenty","year":"2008","unstructured":"Karsenty G, Denys P, Amarenco G et al (2008) Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review. Eur Urol 53:275\u2013287. https:\/\/doi.org\/10.1016\/j.eururo.2007.10.013","journal-title":"Eur Urol"},{"key":"3050_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/SLA.0000000000004251","volume":"275","author":"C Desprez","year":"2022","unstructured":"Desprez C, Damon H, Meurette G et al (2022) Ten-year evaluation of a large retrospective cohort treated by sacral nerve modulation for fecal incontinence: results of a French multicenter study. Ann Surg 275:735\u2013742. https:\/\/doi.org\/10.1097\/SLA.0000000000004251","journal-title":"Ann Surg"},{"key":"3050_CR16","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s13304-023-01570-z","volume":"75","author":"L Brusciano","year":"2023","unstructured":"Brusciano L, Brillantino A, Pellino G et al (2023) Sacral nerve modulation for patients with fecal incontinence: long-term outcome and effects on sexual function. Updates Surg 75:1187\u20131195. https:\/\/doi.org\/10.1007\/s13304-023-01570-z","journal-title":"Updates Surg"},{"key":"3050_CR17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cireng.2022.05.006","volume":"100","author":"MJ de Miguel Valencia","year":"2022","unstructured":"de Miguel Valencia MJ, Margallo Lana A, P\u00e9rez Sola M\u00c1 et al (2022) Economic burden of long-term treatment of severe fecal incontinence. Cir Esp (Engl Ed) 100:422\u2013430. https:\/\/doi.org\/10.1016\/j.cireng.2022.05.006","journal-title":"Cir Esp (Engl Ed)"},{"key":"3050_CR18","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00192-020-04427-w","volume":"32","author":"Q He","year":"2021","unstructured":"He Q, Li B, Zhang C et al (2021) Treatment for refractory overactive bladder: a systematic review and meta-analysis of sacral neuromodulation and onabotulinumtoxinA. Int Urogynecol J 32:477\u2013484. https:\/\/doi.org\/10.1007\/s00192-020-04427-w","journal-title":"Int Urogynecol J"},{"key":"3050_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ijsu.2018.10.041","volume":"60","author":"H-L Niu","year":"2018","unstructured":"Niu H-L, Ma Y-H, Zhang C-J (2018) Comparison of OnabotulinumtoxinA versus sacral neuromodulation for refractory urinary urge incontinence: a systematic review and meta-analysis of randomized controlled trials. Int J Surg 60:141\u2013148. https:\/\/doi.org\/10.1016\/j.ijsu.2018.10.041","journal-title":"Int J Surg"},{"key":"3050_CR20","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1097\/JU.0000000000000656","volume":"203","author":"HS Harvie","year":"2020","unstructured":"Harvie HS, Amundsen CL, Neuwahl SJ et al (2020) Cost-effectiveness of sacral Neuromodulation versus OnabotulinumtoxinA for refractory urgency urinary incontinence: results of the ROSETTA randomized trial. J Urol 203:969\u2013977. https:\/\/doi.org\/10.1097\/JU.0000000000000656","journal-title":"J Urol"},{"key":"3050_CR21","doi-asserted-by":"publisher","first-page":"e220089","DOI":"10.2217\/cer-2022-0089","volume":"12","author":"B Murray","year":"2023","unstructured":"Murray B, Miles-Thomas J, Park AJ et al (2023) Cost-effectiveness of overactive bladder treatments from a US commercial and payer perspective. J Comp Eff Res 12:e220089. https:\/\/doi.org\/10.2217\/cer-2022-0089","journal-title":"J Comp Eff Res"},{"key":"3050_CR22","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1053\/j.gastro.2003.10.056","volume":"126","author":"PB Miner","year":"2004","unstructured":"Miner PB (2004) Economic and personal impact of fecal and urinary incontinence. Gastroenterology 126:S8-13. https:\/\/doi.org\/10.1053\/j.gastro.2003.10.056","journal-title":"Gastroenterology"},{"key":"3050_CR23","doi-asserted-by":"publisher","first-page":"513.e1","DOI":"10.1016\/j.ajog.2019.06.018","volume":"221","author":"UU Andy","year":"2019","unstructured":"Andy UU, Amundsen CL, Honeycutt E et al (2019) Sacral Neuromodulation versus OnabotulinumtoxinA for refractory urgency urinary incontinence: impact on fecal incontinence symptoms and sexual function. Am J Obstet Gynecol 221:513.e1-513.e15. https:\/\/doi.org\/10.1016\/j.ajog.2019.06.018","journal-title":"Am J Obstet Gynecol"},{"key":"3050_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2147\/BTT.S65603","volume":"8","author":"MF Brin","year":"2014","unstructured":"Brin MF, James C, Maltman J (2014) Botulinum toxin type A products are not interchangeable: a review of the evidence. BTT 8:227\u2013241. https:\/\/doi.org\/10.2147\/BTT.S65603","journal-title":"BTT"},{"key":"3050_CR25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1159\/000251175","volume":"83","author":"M Stoehrer","year":"2009","unstructured":"Stoehrer M, Wolff A, Kramer G et al (2009) Treatment of neurogenic detrusor overactivity with botulinum toxin A: the first seven years. Urol Int 83:379\u2013385. https:\/\/doi.org\/10.1159\/000251175","journal-title":"Urol Int"},{"key":"3050_CR26","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","volume":"47","author":"J Grosse","year":"2005","unstructured":"Grosse J, Kramer G, St\u00f6hrer M (2005) Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol 47:653\u2013659. https:\/\/doi.org\/10.1016\/j.eururo.2004.11.009","journal-title":"Eur Urol"},{"key":"3050_CR27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/bju.12028","volume":"112","author":"P Ravindra","year":"2013","unstructured":"Ravindra P, Jackson BL, Parkinson RJ (2013) Botulinum toxin type A for the treatment of non-neurogenic overactive bladder: does using onabotulinumtoxinA (Botox(\u00ae)) or abobotulinumtoxinA (Dysport(\u00ae)) make a difference? BJU Int 112:94\u201399. https:\/\/doi.org\/10.1111\/bju.12028","journal-title":"BJU Int"},{"key":"3050_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1464-410X.2012.11282.x","volume":"111","author":"A Mohee","year":"2013","unstructured":"Mohee A, Khan A, Harris N, Eardley I (2013) Long-term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB). BJU Int 111:106\u2013113. https:\/\/doi.org\/10.1111\/j.1464-410X.2012.11282.x","journal-title":"BJU Int"}],"container-title":["Techniques in Coloproctology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-024-03050-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10151-024-03050-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10151-024-03050-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:58:25Z","timestamp":1766051905000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10151-024-03050-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["3050"],"URL":"https:\/\/doi.org\/10.1007\/s10151-024-03050-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4217302\/v1","asserted-by":"object"}]},"ISSN":["1123-6337","1128-045X"],"issn-type":[{"value":"1123-6337","type":"print"},{"value":"1128-045X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"assertion":[{"value":"4 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study received institutional approval from the data protection officer (DPO) at AP-HM. It was registered under reference number LAEJUL (2023).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Given the retrospective design of the study and in accordance with current regulations in France, no formal consent was required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"22"}}